– Generated Quarterly Net Revenues of $205.4 Million, Up 13% Year-over-Year, and Record Full-Year Net Revenues of $780.6 Million, Up 24% Year-over-Year – – Generated Record Quarterly and Full-Year Jornay PM® Net Revenue of $45.9 Million and $148.9 Million, Up 57% and 48%, Respectively, Year-over-Year – – Generated Quarterly Pain Portfolio Net Revenues of $159.6 Million, Up 5% Year-over-Year, and Record Full-Year Pain Portfolio Net Revenues $631.7 Million, Up 6% Year-over-Year – – Ended 2025 with Cash, Cash ...

TORONTO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Colliers (NASDAQ, TSX: CIGI), a leading diversified professional services and investment management company, has been named to the 2026 Global 100 list produced by IAOP® in the Leader category for large, established global firms. This marks the 20th consecutive year that Colliers has been recognized for global service excellence. IAOP’s annual list recognizes the world’s top outsourcing service providers and advisors based on rigorous evaluation criteria, including ...

Figure 1 MD Projects-Eeyou Istchee James Bay Figure 2 Caniaspic Au 2025 Results Figure 3 Caniapisc Au Planned IP Figure 4 Samples 2025 Figure 5 Samples 2025 Figure 6 Samples 2025 MONTREAL, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Midland Exploration Inc. (“Midland”) (TSX-V: MD) is pleased to announce the start of an induced polarization ground (“IP’) geophysical survey on its Caniapisc Au project, in the Eeyou Istchee James Bay and Caniapiscau regions. The Caniapisc Au project is wholly ...

Vancouver, British Columbia, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Initial prospecting results and geological observations suggest that the broader area encompassing North American Niobium and Critical Minerals Corp.’s (CSE: NIOB) (OTCQB: NIOMF) (FSE: KS82.F) Bardy, Blanchette and Sabot projects in Québec may be comparable in style to the large rare-earth element (REE) deposits found in Greenland. As such, the Company has begun a technical review aimed at assessing Sabot’s potential to be incorporated into near ...

TORONTO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today provided an update on the timing of its Premarket Approval (“PMA”) submission to the U.S. Food and Drug Administration (“FDA”) for its hemoadsorption device to treat endotoxic septic shock. Following recent interaction with the FDA, the Company now expects to submit its PMA around the end of April to mid-M ...

JENA, Germany, Feb. 26, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced it will participate in the Leerink Partners Global Healthcare Conference. Details are as follows: Leerink Partners Global Healthcare ConferenceMarch 8 - 11, 2026 in Miami, FLFireside chat on March 9 at 9:20 AM ET InflaRx will also conduct one-on-one investor meetings on March 9th. A link to view the fireside ch ...

GAITHERSBURG, Md., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing pemvidutide to address serious liver diseases, today announced that it will report its fourth quarter 2025 financial results on Thursday, March 5, 2026. Altimmune management will host a conference call at 8:30 a.m. ET on March 5 to discuss the financial results and provide a business update. The conference call will be webcast live on Altimmune’s Investor Relations w ...

Rare earth element and niobium anomalies found in sediments and surrounding rocksVancouver, British Columbia, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Initial prospecting results and geological observations suggest that the broader area encompassing North American Niobium and Critical Minerals Corp.’s (CSE: NIOB) (OTCQB: NIOMF) (FSE: KS82.F) Bardy, Blanchette and Sabot projects in Québec may be comparable in style to the large rare-earth element (REE) deposits found in Greenland. As such, the Company has begun a t ...

Positive Phase 3 data from ORIGIN 3 study of atacicept in IgA nephropathy (IgAN) presented at American Society of Nephrology (ASN) Kidney Week and published in the New England Journal of MedicineU.S. Food and Drug Administration (FDA) granted priority review to Biologics License Application (BLA) for atacicept with Prescription Drug User Fee Act (PDUFA) date of July 7, 2026; potential commercial launch of atacicept expected in mid-2026Strong balance sheet bolstered by equity and debt financings in 2025 expe ...

Giant Containers to design and build critical infrastructure and community amenities for transformative urban state park spanning northern New JerseyCONROE, Texas, Feb. 26, 2026 (GLOBE NEWSWIRE) -- via IBN — Olenox Industries Inc. (NASDAQ: OLOX) (“Olenox Industries” or the “Company”) today announced that its subsidiary, Giant Containers, has been selected to provide design and construction services for critical infrastructure and amenities as part of the nearly one-mile Newark segment of New Jersey’s newest ...